Table of Contents Table of Contents
Previous Page  356 / 2894 Next Page
Information
Show Menu
Previous Page 356 / 2894 Next Page
Page Background

356

Farmacología y anestesia

II

Ca

2+

sensitivity in airway smooth muscle. J Appl

Physiol 92:257, 2002.

8. Hirshman CA, Lande B, Croxton TL: Role of M

2

muscarinic receptors in airway smooth muscle con-

traction. Life Sci 64:443, 1999.

9. Groeben H, Brown RH: Ipratropium decreases

airway size in dogs by preferential M

2

muscarinic

receptor blockade in vivo. Anesthesiology 85:867,

1996.

10. Emala CW, McQuitty CK, Eleff SM, et al: Asthma,

allergy, and airway hyperresponsiveness are not

linked to the beta(2)-adrenoceptor gene. Chest

121:722, 2002.

11. Park KW, Sato K, Dai HB, et al: Epithelium-depen-

dent bronchodilatory activity is preserved in pig

bronchioles after normothermic cardiopulmonary

bypass. Anesth Analg 90:778, 2000.

12. Fehr JJ, Hirshman CA, Emala CW: Cellular signa-

ling by the potent bronchoconstrictor endothelin-1

in airway smooth muscle. Crit Care Med 28:1884,

2000.

13. D’Angelo E, Calderini IS, Tavola M: The effects of

CO

2

on respiratory mechanics in anesthetized

paralyzed humans. Anesthesiology 94:604, 2001.

14. Mazzeo AJ, Cheng EY, Stadnicka A, et al: Topogra-

phic differences in the direct effects of isoflurane on

airway smooth muscle. Anesth Analg 78:948, 1994.

15. Park KW, Dai HB, Lowenstein E, et al: Isoflurane-

and halothane-mediated dilation of distal bronchi

in the rat depends on the epithelium. Anesthesio-

logy 86:1078, 1997.

16. Habre W, Petak F, Sly PD, et al: Protective effects of

volatile agents against methacholine-induced bron-

choconstriction in rats. Anesthesiology 94:348, 2001.

17. Brown RH, Mitzner W, Zerhouni E, et al: Direct in

vivo visualization of bronchodilation induced by

inhalational anesthesia using high-resolution com-

puted tomography. Anesthesiology 78:295, 1993.

18. Brown RH, Zerhouni E, Hirshman CA: Compari-

son of low concentrations of halothane and isoflu-

rane as bronchodilators. Anesthesiology 78:1097,

1993.

19. Yamamoto K, Morimoto N, Warner DO, et al:

Factors influencing the direct actions of volatile

anesthetics on airway smooth muscle. Anesthesio-

logy 78:1102, 1993.

20. Mitsuhata H, Saitoh J, Shimizu R, et al: Sevoflurane

and isoflurane protect against bronchospasm in

dogs. Anesthesiology 81:1230, 2004.

21. Katoh T, Ikeda KCJA: A comparison of sevoflurane

with halothane, enflurane, and isoflurane on bron-

choconstriction caused by histamine.Can J Anaesth

41:1214, 1994.

22. Cheng EY, Mazzeo AJ, Bosnjak ZJ, et al: Direct

relaxant effects of intravenous anesthetics on airway

smooth muscle. Anesth Analg 83:162, 1996.

23. Mazzeo AJ, Cheng EY, Bosnjak ZJ, et al: Differential

effects of desflurane and halothane on peripheral

airway smooth muscle. Br J Anaesth 76:841, 1996.

24. Goff MJ, Arain SR, Ficke DJ, et al: Absence of bron-

chodilation during desflurane anesthesia: A compa-

rison to sevoflurane and thiopental.Anesthesiology

93:404, 2000.

25. Yamakage M, Chen X, Tsuijiguchi N, et al: Different

inhibitory effects of volatile anesthetics on T- and

L-type voltage-dependent Ca

2+

channels in porcine

tracheal and bronchial smooth muscles. Anesthe-

siology 94:683, 2001.

26. Crawford MW, Arrica M, Macgowan CK, Yoo S-J:

Extent and localization of changes in upper airway

caliber with varying concentrations of sevoflurane

in children. Anesthesiology 105:1147, 2006.

27. Dikmen Y, Eminoglou E, Salihoglou Z, Demiroluk

S: Pulmonary mechanics during isoflurane, sevoflu-

rane and desflurane anesthesia. Anaesthesia 58:745,

2003.

28. Hashimoto Y, Hirota K, Ohtomo N, et al: In vivo

direct measurement of the bronchodilating effect of

sevoflurane using a superfine fiberoptic bronchos-

cope: Comparison with enflurane and halothane. J

Cardiothorac Vasc Anesth 10:213, 1996.

29. Iwasaki S, Yamakage M, Satoh J-I, Namiki A: Diffe-

rent inhibitory effects of sevoflurane on hyperreac-

tive airway smooth muscle contractility in

ovalbumin-sensitized and chronic cigarette-smo-

king guinea pig models. Anesthesiology 105:753,

2006.

30. Yamakage M: Direct inhibitory mechanisms of

halothane on canine tracheal smooth muscle con-

traction. Anesthesiology 77:546, 1992.

31. Nyktari VG, Papaioannou AA, Prinianakis G, et al:

Effect of the physical properties of isoflurane, sevo-

flurane and desflurane on pulmonary resistance in

a laboratory lung model. Anesthesiology 104:1202,

2006.

32. Kai T, Jones KA, Warner DO: Halothane attenuates

calcium sensitization in airway smooth muscle by

inhibiting G-proteins. Anesthesiology 89:1543,

1998.

33. Janssen LJ: T-type and L-type Ca

2+

currents in

canine bronchial smooth muscle: Characterization

and physiological roles. Am J Physiol Cell Physiol

272:C1757, 1997.

34. Chen X, Yamakage M, Namiki A: Inhibitory effects

of volatile anesthetics on K

+

and Cl

channel

currents in porcine tracheal and bronchial smooth

muscle. Anesthesiology 96:458, 2002.

35. Yamakage M, Chen X, Kimura A, et al: The repola-

rizing effects of volatile anesthetics on porcine tra-

cheal and bronchial smooth muscle cells. Anesth

Analg 94:84, 2002.

36. Fukushima T, Hirasaki A, Jones KA, et al: Halothane

and potassium channels in airway smooth muscle.

Br J Anaesth 76:847, 1996.

37. Pabelick CM, Prakash YS, Kannan MS, et al: Effect

of halothane on intracellular calcium oscillations in

porcine tracheal smooth muscle cells. Am J Physiol

Lung Cell Mol Physiol 276:L81, 1999.

38. Pabelick CM, Prakash YS, Kannan MS, et al: Effects

of halothane on sarcoplasmic reticulum calcium

release channels in porcine airway smooth muscle

cells. Anesthesiology 95:207, 2001.

39. Kai T, Bremerich DH, Jones KA,Warner DO: Drug-

specific effects of volatile anesthetics on Ca

2+

sensi-

tization in airway smooth muscle. Anesthesiology

87:425, 1998.

40. Hanazaki M, Jones KA, Perkins WJ, et al: Halothane

increases smooth muscle protein phosphatase in

airway smooth muscle. Anesthesiology 94:129, 2001.

41. Jones KA, Wong GY, Jankowski CJ, et al: cGMP

modulation of Ca

2+

sensitivity in airway smooth

muscle. Am J Physiol Lung Cell Mol Physiol

276:L35, 1999.

42. Morimoto N, Yamamoto K, Jones KA, et al: Halo-

thane and pertussis toxin–sensitive G proteins in

airway smooth muscle. Anesth Analg 78:328, 1994.

43. Sakihara C, Perkins WJ, Warner DO, Jones KA:

Anestheticsinhibitacetylcholine-promotedguanine

nucleotide exchange of heterotrimeric G proteins of

airway smooth muscle. Anesthesiology 101:120,

2004.

44. Duracher C, Blanc F-X, Gueugniaud P-Y, et al: The

effects of isoflurane on airway kinetics in Fisher and

Lewis rats. Anesth Analg 101:136, 2005.

45. Park KW, Dai HB, Lowenstein E, et al: Epithelial

dependence of the bronchodilatory effect of sevo-

flurane and desflurane in rat distal bronchi. Anesth

Analg 86:646, 1998.

46. Mougdil GC: The patient with reactive airways

disease. Can J Anaesth 44:R77, 1997.

47. Warner DO, Brichant J-F, Rehder K: Direct and

neurally mediated effects of halothane on pulmo-

nary resistance in vivo. Anesthesiology 72:1057,

1990.

48. Wiklund CU, Lim S, Lindsten U, et al: Relaxation by

sevoflurane, desflurane and halothane in the isola-

ted guinea-pig trachea via inhibition of cholinergic

neurotransmission. Br J Anaesth 83:422, 1999.

49. Lindeman KS, Baker SG, Hirshman CA: Interaction

between halothane and the nonadrenergic, noncho-

linergic inhibitory system in porcine trachealis

muscle. Anesthesiology 81:641, 1994.

50. Akhtar S, Brull SJ: Effect of isoflurane on endothe-

lin-1 mediated airway smooth muscle contraction.

Pulm Pharmacol Ther 11:227, 1998.

51. Arakawa H, Takizawa T, Tokuyama K, et al: Efficacy

of inhaled anticholinergics and anesthesia in

treatment of a patient in status asthmaticus. J

Asthma 39:77, 2002.

52. Saulnier FF, Durocher AV, Deturck RA, et al: Respi-

ratory and hemodynamic effects of halothane in

status asthmaticus. Intensive Care Med 16:104,

1990.

53. Rooke GA, Choi J-H, Bishop MJ: The effect of iso-

flurane, halothane, sevoflurane, and thiopental/

nitrous oxide on respiratory system resistance after

tracheal intubation. Anesthesiology 86:1294, 1997.

54. Tobias JD,Hirshman CA:Attenuation of histamine-

induced airway constriction by albuterol during

halothane anesthesia. Anesthesiology 72:105, 1990.

55. Wu RSC,Wu KC,Wong TKM, et al: Isoflurane anes-

thesia does not add to the bronchodilating effect of

a beta 2-adrenergic agonist after tracheal intuba-

tion. Anesth Analg 83:238, 1996.

56. Yamakage M, Tsujiguchi N, Hattori J-I, et al: Low-

temperature modification of the inhibitory effects

of volatile anesthetics on airway smooth muscle

contraction in dogs. Anesthesiology 93:179, 2000.

57. Volta CA, Alvisi V, Petrini S, el al: The effect of

volatile anesthetics on respiratory system resistance

in patients with chronic obstructive pulmonary

disease. Anesth Analg 100:348, 2005.

58. Burburan SM, Xisto D, Ferreira HC, et al: Lung

mechanics and histology during sevoflurane anes-

thesia in a model of chronic allergic asthma.Anesth

Analg 104:631, 2007.

59. Goto T, Nakata Y, Morita S:Will xenon be a stranger

or a friend? The cost, benefit, and future of xenon

anesthesia. Anesthesiology 98:1, 2003.

60. Preckel B, Weber NC, Sanders RD, et al: Molecular

mechanisms transducing the anesthetic, analgesic,

and organ-protective actions of xenon. Anesthesio-

logy 105:187, 2006.

61. Rueckoldt H, Vangerow B, Marx G, et al: Xenon

inhalation increases airway pressure in ventilated

patients. Acta Anaesthesiol Scand 43:1060, 1999.

62. Calzia E, Stahl W, Handschuh T, et al: Respiratory

mechanics during xenon anesthesia in pigs: Com-

parison with nitrous oxide.Anesthesiology 91:1378,

1999.

63. Fujii Y: Respiratory effects of xenon. Int Anesthesiol

Clin 39:95, 2001.

64. Zhang P, Ohara A, Mashimo T, et al: Pulmonary

resistance in dogs: A comparison of xenon with

nitrous oxide. Can J Anaesth 42:547, 1995.

65. Lachmann B,Armbruster S, Schairer W, et al: Safety

and efficacy of xenon in routine use as an inhalatio-

nal anaesthetic. Lancet 335:1413, 1995.

66. Calzia E, Stahl W, Handschuh T, et al: Continuous

arterial Po

2

and Pco

2

measurements in swine

during nitrous oxide and xenon elimination: Pre-

vention of diffusion. Anesthesiology 90:829, 1999.